Association Of Clinical And Radiological Factors With The Outcomes Of Central Venoplasty Among End-Stage Renal Disease Patients In Hospital Universiti Sains Malaysia
Keywords:
Central venous stenosis (CVS), Central venoplasty, Length of stenosis, Degree of stenosis, Location of stenosisAbstract
Background: Central venous stenosis is a common complication in end-stage renal disease patients receiving hemodialysis therapy with central venous catheters, and central venoplasty is the mainstay treatment. However, not all patients undergoing central venoplasty have a successful outcome. This study aims to determine the association between radiological factors and clinical factors determining the success rate of central venoplasty.Â
Methodology: A retrospective cross-sectional study conducted in Advanced Minimally Invasive Endovascular and Neurointervention (AMIEN) Unit, Hospital Universiti Sains Malaysia (HUSM) on 62 patients with central venous stenosis or occlusion and treated with central venoplasty in Hospital HUSM from 1st January 2016 until 31st August 2020. Radiological variables (location, grade, and length of stenosis) and clinical variables (gender, diabetes mellitus (DM), and hypertension (HPT)) are assessed before central venoplasty. The association between the radiological and clinical factors with the outcome of central venoplasty was assessed using Chi-Square Test.
Results: A total of 62 patients were included in our study. There was no significant association between the location of veins, degree, and length of stenosis with the successful outcome.
However, a single vein had a significantly higher success rate (92.6%) than multiple veins (7.4%). Apart from the radiological factors, the clinical factors (gender, DM, and HPT) also show no significant association in determining successful outcomes with p values 0.159, 0.644, and 0.283 respectively (more than 0.05).
Conclusion: There is no association of clinical and radiological factors with the outcomes of central venoplasty among end-stage renal disease patients. A further study needs to be conducted with a larger sample size and other possible determining factors to help facilitate the procedure in the future.
References
Cuthbert GA, Lo ZJ, Kwan J, Chandrasekar S, Tan GWL. Outcomes of Central Venoplasty in Haemodialysis Patients. Ann Vasc Dis. 2018;11(3):292-297. doi:10.3400/avd.oa.18-00025
Modabber M, Kundu S. Central venous disease in hemodialysis patients: An update. Cardiovasc Intervent Radiol. 2013;36(4):898-903. doi:10.1007/s00270-012-0498-6
Lumsden AB, Macdonald MJ, Isiklar H, et al. Central Venous Stenosis in the Hemodialysis Patient: Incidence and Efficacy of Endovascular Treatment. Vol 5.; 1997.
Huang Y, Chen B, Tan G, et al. The feasibility and safety of a through-and-through wire technique for central venous occlusion in dialysis patients. BMC Cardiovasc Disord.
;16(1). doi:10.1186/s12872-016-0411-3
Kovalik EC, Newman GE, Suhociu P, Knelson M, Schwab SJ. Correction of Central Venous
Stenoses: Use of Angioplasty and Vascular Walistents. Vol 45.; 1994.
Medicine. Dialysis Access Grafts: Anatomic Location OfVenous Stenosis and Results of Angioplasty' From the Departments of Radiology.
Maeda K, Furukawa A, Yamasaki M, Murata K. Percutaneous transluminal angioplasty for Brescia-Cimino hemodialysis fistula dysfunction: Technical success rate, patency rate and factors that influence the results. Eur J Radiol. 2005;54(3):426-430.
doi: 10.1016/j.ejrad.2004.07.011
Adwaney A, Lim C, Blakey S, Duncan N, Ashby DR. Central venous stenosis, access outcome and survival in patients undergoing maintenance hemodialysis. Clinical Journal of the
American Society of Nephrology. 2019;14(3):378-384. doi:10.2215/CJN.07010618
Heye S, Maleux G, Vaninbroukx J, Claes K, Kuypers D, Oyen R. Factors influencing technical success and outcome of percutaneous balloon angioplasty in de novo native
hemodialysis arteriovenous fistulas. Eur J Radiol. 2012;81(9):2298-2303. doi: 10.1016/j.ejrad.2011.09.004
Medicine. Dialysis Access Grafts: Anatomic Location OfVenous Stenosis and Results of Angioplasty' From the Departments of Radiology.
Romann A, Beaulieu MC, Rhéaume P, Clement J, Sidhu R, Kiaii M. Risk factors associated with arteriovenous fistula failure after the first radiologic intervention. Journal of Vascular
Access. 2016;17(2):167-174. doi:10.5301/jva.5000459
Sidhu A, Tan KT, Noel-Lamy M, Simons ME, Rajan DK. Does Technical Success of Angioplasty in Dysfunctional Hemodialysis Accesses Correlate with Access Patency? Cardiovasc
Intervent Radiol. 2016;39(10):1400-1406. doi:10.1007/s00270-016-1401-7
Surowiec SM, Fegley AJ, Tanski WJ, et al. Endovascular Management of Central Venous
Stenoses in the Hemodialysis Patient: Results of Percutaneous Therapy.
Dolmatch BL, Gurley JC, Baskin KM, et al. Society of Interventional Radiology Reporting Standards for Thoracic Central Vein Obstruction: Endorsed by the American Society of Diagnostic and Interventional Nephrology (ASDIN), British Society of Interventional Radiology (BSIR), Canadian Interventional Radiology Association (CIRA), Heart Rhythm Society
(HRS), Indian Society of Vascular and Interventional Radiology (ISVIR), Vascular Access
Society of the Americas (VASA), and Vascular Access Society of Britain and Ireland
(VASBI). Journal of Vascular and Interventional Radiology. 2018;29(4):454-460.e3. doi: 10.1016/j.jvir.2017.12.013
Surgery, Washington. Upper Extremity Central Venous Obstruction In Hemodialysis Patients: Treatment with Walistents' I From the Departments of Diagnostic Radiology,
Mallinckrodt Institute of Radiology. Vol 204.; 1997.
Surgery, Washington. Upper Extremity Central Venous Obstruction In Hemodialysis Patients: Treatment with Walistents' I From the Departments of Diagnostic Radiology,
Mallinckrodt Institute of Radiology. Vol 204.; 1997.
Bakken AM, Protack CD, Saad WE, Lee DE, Waldman DL, Davies MG. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients. J Vasc Surg. 2007;45(4):776-783. doi: 10.1016/j.jvs.2006.12.046
Thwaites SE, Robless PA. Central vein stenosis in an Asian hemodialysis population. Asian
Cardiovasc Thorac Ann. 2012;20(5):560-565. doi:10.1177/0218492312449634
Hongsakul K, Leelarujijaroen P, Boonsrirat U. Outcome of central vein occlusion recanalization in hemodialysis patients and predictors for success: A retrospective study. J Belg Soc
Radiol. 2020;104(1):1-8. doi:10.5334/jbsr.1991
Harris RC, Zhang MZ. The role of gender disparities in kidney injury. Ann Transl Med.
;8(7):514-514. doi:10.21037/atm.2020.01.23
Neuen BL, Gunnarsson R, Webster AC, Baer RA, Golledge J, Mantha ML. Predictors of patency after balloon angioplasty in hemodialysis fistulas: A systematic review. Journal of Vascular and Interventional Radiology. 2014;25(6):917-924. doi: 10.1016/j.jvir.2014.02.010
Rehman ZU, Hakeem A, Sayyani R, Zahid N. Percutaneous venoplasty for central venous stenosis: Effect on patient's symptoms and patency of arteriovenous accesses. Journal of the
College of Physicians and Surgeons Pakistan. 2019;29(12):1189-1192. doi:10.29271/jcpsp.2019.12.1189
Surgery E. Jinasvs © 2020. 2020;1(1):6-9.
Calton RK, Shikoh MF, Padiyara AJ, Calton NR, Das J, Pawar B. Brachiocephalic Venoplasty and Stenting in patients with central venous stenosis. IHJ Cardiovascular Case Reports (CVCR). 2021;5(3):125-129. doi: 10.1016/j.ihjccr.2021.10.010
Downloads
Published
Issue
Section
License
JBCS Publication Ethics
JBCS is committed to ensure the publication process follows specific academic ethics. Hence, Authors, Reviewers and Editors are required to conform to standards of ethical guidelines.
Authors
Authors should discuss objectively the significance of research work, technical detail and relevant references to enable others to replicate the experiments. JBCS do not accept fraudulent or inaccurate statements that may constitute towards unethical conduct.
Authors should ensure the originality of their works. In cases where the work and/or words of others have been used, appropriate acknowledgements should be made. JBCS do not accept plagiarism in all forms that constitute towards unethical publishing of an article.
This includes simultaneous submission of the same manuscript to more than one journal. Corresponding author is responsible for the full consensus of all co-authors in approving the final version of the paper and its submission for publication.
Reviewers
Reviewers of JBCS treat manuscripts received for review as confidential documents. Therefore, Reviewers must ensure the confidentiality and should not use privileged information and/or ideas obtained through peer review for personal advantage.
Reviews should be conducted based on academic merit and observations should be formulated clearly with supporting arguments. In cases where selected Reviewer feels unqualified to review a manuscript, Reviewer should notify the editor and excuse himself from the review process in TWO (2) weeks time from the review offer is made.
In any reasonable circumstances, Reviewers should not consider to evaluate manuscripts if they have conflicts of interest (i.e: competitive, collaborative and/or other connections with any of the authors, companies, or institutions affiliated to the papers).
Editors
Editors should evaluate manuscripts exclusively based on their academic merit. JBCS strictly do not allow editors to use unpublished information of authors without the written consent of the author. Editors are required to take appropriate responsive actions if ethical complaints have been presented concerning a submitted manuscript or published paper.
CONFLICT OF INTEREST
Journal of Biomedical and Clinical Sciences requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a ‘competing interests section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read ,The authors have declared that no competing interests exist. Editors may ask for further information relating to competing interests.
Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists. Competing interests may be financial or non-financial. A competing interest exists when the authors interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.
HUMAN AND ANIMAL RIGHTS
All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s) institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. Further information and documentation to support this should be made available to Editors on request.
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.
A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.
INFORMED CONSENT
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript, this includes to all manuscripts that include details, images, or videos relating to individual participants.
DATA SHARING POLICY
JBCS strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files, in machine-readable format (such as spreadsheets rather than PDFs) whenever possible
Authors who do not wish to share their data must state that data will not be shared, and give the reason.
COPYRIGHT NOTICE
The JBCS retains the copyright of published manuscripts under the terms of the Copyright Transfer Agreement. However, the journal permits unrestricted use, distribution, and reproduction in any medium, provided permission to reuse, distribute and reproduce is obtained from the Journal's Editor and the original work is properly cited.
While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
Copyright (c) 2023 Journal of Biomedical and Clinical Sciences (JBCS)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
